Monographie - Neostigmine methylsulfate

Zadnji put ažurirano :
08/05/2024

Neostigmine methylsulfate

Kemijska struktura

Nekomercijalni

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Adwigmine	Egipat
Amostigmine	Egipat
Beemine	Indija
Bloxiverz
Epistigmine	Egipat
Fadastigmina	Argentina, Italija, Portugal
Ipostigmine	Iran
Miostin	Rumunjska
Neostig	Njemačka
Neostigmin	Njemačka, Švedska
Neostigmina	Argentina, Čile, Ekvador, Kolumbija, Peru, Portugal, Španjolska, Venecuela
Neostigmine	Australija, Egipat, Grčka, Irska, Kanada, Malezija, Nizozemska, Novi Zeland, Saudijska Arabija, Turska, Velika Britanija
Neostigmine methylsulfate	Kanada
Neostigten	Peru
Normastigmin	Austrija
Planstigmin	Turska
Polstigminum	Poljska
Prostigmin	Austrija, Belgija, Grčka, Malezija, Nizozemska, Švicarska
Prostigmina	Italija
Prostigmine	Belgija, Čile, Egipat, Francuska, Kolumbija, Luksemburg, Maroko, Meksiko, Španjolska, Ujedinjeni Arapski Emirati, Venecuela
Setisin	Malezija
Stigmosan	Madžarska
Tigmin	Peru
Visulmin	Meksiko

Bibliografija : Neostigmine methylsulfate

	Vrsta	Publikacija
815	Časopis	Stewart JT, Warren FW, King DT, Venkateshwaran TG, Fox JL. Stability of ondansetron hydrochloride and 12 medications in plastic syringes. Am J Health-Syst Pharm 1998 ; 55: 2630-2634.
1200	Časopis	Chaudry IA, Bruey KP, Hurlburt LE, Oden EM. Compatibility of netilmycin sulfate injection with commonly used intravenous injections and additives. Am J Hosp Pharm 1981 ; 38: 1737-1742.
1228	Časopis	Allen LV, Stiles ML. Compatibility of various admixtures at Y-injection sites of intravenous administration sets. Part2. Am J Hosp Pharm 1981 ; 38: 380-381.
1682	Časopis	Storms M, Stewart JT, Warren FW. Stability of neostigmine methylsulfate injection at ambient temperature and 4°C in polypropylene syringes. Int J Pharm Compound 2002 ; 6: 475-477.
2286	Časopis	Ben M, Trusley C, Kupiec TC, Trissel LA. Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated Y-site administration. Int J Pharm Compound 2008 ; 12, 4: 368-371.
2291	Časopis	Yeh MK. Degradation kinetics of neostigmine in solution. Drug Dev Ind Pharm 2000 ; 26, 11: 1221-1226.
3372	Časopis	Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S. Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine. Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3578	Laboratorija	Cisplatin - Summary of Product Characteristics Accord Healthcare 2011
3599	Laboratorija	Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics Amco Amdipharm Mercry 2013
3644	Laboratorija	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010

Mentions Légales